Market Tracker

10/01 6:05pm ET

Trovagene Inc (NASDAQ:TROV)

4.31
Data as of 3:59pm ET
 -0.27 / -5.90%
Today’s Change
2.97
Today|||52-Week Range
8.50
-24.91%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close4.58
Today’s open4.43
Day’s range4.12 - 4.58
Volume127,932
Average volume (3 months)167,971
Market cap$86.6M
Dividend yield--
Data as of 3:59pm ET, 10/01/2014

Growth & Valuation

Earnings growth (last year)+21.35%
Earnings growth (this year)-11.43%
Earnings growth (next 5 years)--
Revenue growth (last year)-42.44%
P/E ratioNM
Price/Sales375.92
Price/Book4.25

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc-0.05-0.56%
LPDXLipoScience Inc+0.01+0.19%
GALTGalectin Therapeutic...-0.19-3.78%
APPYVenaxis Inc-0.06-3.61%
Data as of 4:14pm ET, 10/01/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$259.2K
Annual profit (last year)-$11.8M
Net profit margin-4,555.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts